首页 > 最新文献

Airway Pharmacology and Treatment最新文献

英文 中文
Asleep fibreoptic bronchoscope-guided nasal intubation in a child with bilateral temporomandibular joint ankylosis 纤维支气管镜引导下的睡眠鼻插管治疗双侧颞下颌关节强直患儿1例
Pub Date : 2022-05-01 DOI: 10.4103/arwy.arwy_20_22
N. Panse, Sumedha Mehta, K. Adate, Priyanka Gangthade
Pierre Robin sequence (PRS) with bilateral temporomandibular joint (TMJ) ankylosis is a rare and challenging case for anaesthesiologists. A 6-year-old girl with PRS along with bilateral progressive TMJ ankylosis was scheduled for gap arthroplasty. Her mouth opening was <1 finger. Securing the airway in a syndromic child with mandibular hypoplasia was challenging. We performed an asleep fibreoptic bronchoscope (FOB)-guided nasotracheal intubation while retaining spontaneous breathing. Managing a difficult paediatric airway needs expertise. We believe that with the use of FOB, difficult airways can be successfully and safely managed.
皮埃尔罗宾序列(PRS)与双侧颞下颌关节(TMJ)强直是一个罕见的和具有挑战性的情况下,麻醉师。一名6岁女孩,PRS伴双侧进行性TMJ强直,计划行间隙关节置换术。她的开口是<1指。固定气道综合征儿童下颌骨发育不全是具有挑战性的。我们进行了睡眠纤维支气管镜(FOB)引导下的鼻气管插管,同时保持自主呼吸。处理困难的儿科气道需要专业知识。我们相信,使用FOB,困难的航线可以成功和安全地管理。
{"title":"Asleep fibreoptic bronchoscope-guided nasal intubation in a child with bilateral temporomandibular joint ankylosis","authors":"N. Panse, Sumedha Mehta, K. Adate, Priyanka Gangthade","doi":"10.4103/arwy.arwy_20_22","DOIUrl":"https://doi.org/10.4103/arwy.arwy_20_22","url":null,"abstract":"Pierre Robin sequence (PRS) with bilateral temporomandibular joint (TMJ) ankylosis is a rare and challenging case for anaesthesiologists. A 6-year-old girl with PRS along with bilateral progressive TMJ ankylosis was scheduled for gap arthroplasty. Her mouth opening was <1 finger. Securing the airway in a syndromic child with mandibular hypoplasia was challenging. We performed an asleep fibreoptic bronchoscope (FOB)-guided nasotracheal intubation while retaining spontaneous breathing. Managing a difficult paediatric airway needs expertise. We believe that with the use of FOB, difficult airways can be successfully and safely managed.","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"16 1","pages":"88 - 91"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74522238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Budesonide reduces the bronchial epithelial response to a viral mimic in T2high asthma, and boosts anti-microbial responses in T2low asthma 布地奈德降低t2高哮喘患者对病毒模拟物的支气管上皮反应,增强t2低哮喘患者的抗微生物反应
Pub Date : 2022-03-10 DOI: 10.1183/23120541.lsc-2022.89
J. Nieto-Fontarigo, M. Hvidtfeldt, S. Cerps, S. Ramu, M. Menzel, A. Sverrild, L. Uller, C. Porsbjerg
{"title":"Budesonide reduces the bronchial epithelial response to a viral mimic in T2high asthma, and boosts anti-microbial responses in T2low asthma","authors":"J. Nieto-Fontarigo, M. Hvidtfeldt, S. Cerps, S. Ramu, M. Menzel, A. Sverrild, L. Uller, C. Porsbjerg","doi":"10.1183/23120541.lsc-2022.89","DOIUrl":"https://doi.org/10.1183/23120541.lsc-2022.89","url":null,"abstract":"","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"64 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78794052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of probiotics in uncontrolled asthma 益生菌对未控制哮喘的影响
Pub Date : 2022-03-10 DOI: 10.1183/23120541.lsc-2022.169
C. Moermans, S. Graff, Medard Laurie, Schleich Florence, V. Paulus, F. Guissard, M. Henket, R. Louis
{"title":"Effects of probiotics in uncontrolled asthma","authors":"C. Moermans, S. Graff, Medard Laurie, Schleich Florence, V. Paulus, F. Guissard, M. Henket, R. Louis","doi":"10.1183/23120541.lsc-2022.169","DOIUrl":"https://doi.org/10.1183/23120541.lsc-2022.169","url":null,"abstract":"","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"41 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73043196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human plasma-derived IgG protects against respiratory pathogens in an epithelial air-liquid interface model 人血浆源性IgG在上皮气液界面模型中对呼吸道病原体具有保护作用
Pub Date : 2022-03-10 DOI: 10.1183/23120541.lsc-2022.73
S. Graeter, Anna Schnell, Joseph Bain, Ilka Schulze, C. Vonarburg, A. Schaub
{"title":"Human plasma-derived IgG protects against respiratory pathogens in an epithelial air-liquid interface model","authors":"S. Graeter, Anna Schnell, Joseph Bain, Ilka Schulze, C. Vonarburg, A. Schaub","doi":"10.1183/23120541.lsc-2022.73","DOIUrl":"https://doi.org/10.1183/23120541.lsc-2022.73","url":null,"abstract":"","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"100 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77235073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The bronchodilatory and anti-inflammatory effect of TRPV4 ion channels blocker in experimentally-induced allergic asthma. TRPV4离子通道阻滞剂对实验性过敏性哮喘的支气管扩张和抗炎作用。
Pub Date : 2022-03-10 DOI: 10.1183/23120541.lsc-2022.71
M. Šutovská, J. Mažerik, M. Kocmálová, S. Fraňová
{"title":"The bronchodilatory and anti-inflammatory effect of TRPV4 ion channels blocker in experimentally-induced allergic asthma.","authors":"M. Šutovská, J. Mažerik, M. Kocmálová, S. Fraňová","doi":"10.1183/23120541.lsc-2022.71","DOIUrl":"https://doi.org/10.1183/23120541.lsc-2022.71","url":null,"abstract":"","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74791173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sphingosine-1-phosphate drives sex-dimorphism in lung function 鞘氨醇-1-磷酸驱动肺功能的性别二态性
Pub Date : 2022-03-10 DOI: 10.1183/23120541.lsc-2022.207
I. Cerqua, E. Granato, M. Riemma, A. Rossi, R. Sorrentino, G. Cirino, F. Roviezzo
{"title":"Sphingosine-1-phosphate drives sex-dimorphism in lung function","authors":"I. Cerqua, E. Granato, M. Riemma, A. Rossi, R. Sorrentino, G. Cirino, F. Roviezzo","doi":"10.1183/23120541.lsc-2022.207","DOIUrl":"https://doi.org/10.1183/23120541.lsc-2022.207","url":null,"abstract":"","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"15 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73107800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic unpredictable stress exacerbates allergic airway inflammation in mice. 慢性不可预测的压力加剧了小鼠的过敏性气道炎症。
Pub Date : 2022-03-10 DOI: 10.1183/23120541.lsc-2022.28
Guilherme Dragunas, M. A. de Oliveira, W. Tavares-de-Lima, R. Gosens, C. Munhoz
{"title":"Chronic unpredictable stress exacerbates allergic airway inflammation in mice.","authors":"Guilherme Dragunas, M. A. de Oliveira, W. Tavares-de-Lima, R. Gosens, C. Munhoz","doi":"10.1183/23120541.lsc-2022.28","DOIUrl":"https://doi.org/10.1183/23120541.lsc-2022.28","url":null,"abstract":"","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"13 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73249294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anaesthesia in a patient with seckel syndrome - Plan for contingencies 塞克尔综合征患者的麻醉-应急计划
Pub Date : 2022-01-01 DOI: 10.4103/arwy.arwy_1_22
S. Rawlani, M. Nandini
{"title":"Anaesthesia in a patient with seckel syndrome - Plan for contingencies","authors":"S. Rawlani, M. Nandini","doi":"10.4103/arwy.arwy_1_22","DOIUrl":"https://doi.org/10.4103/arwy.arwy_1_22","url":null,"abstract":"","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"26 1","pages":"61 - 62"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76651797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhaled nitric oxide therapy for pulmonary arterial hypertension of newborn: Eight-year experience of a level IIIB unit 吸入一氧化氮治疗新生儿肺动脉高压:IIIB级单位8年经验
Pub Date : 2022-01-01 DOI: 10.4103/arwy.arwy_57_21
V. Anand, Femitha Pournami, A. Prithvi, Anand Nandakumar, Jyothi Prabhakar, Naveen Jain
Background: Inhaled nitric oxide (iNO) has been in use for several decades now in neonates with hypoxic respiratory failure (HRF) associated with pulmonary hypertension (PH). Its requirement is uncommon, and is considered as an advanced form of support that is not widely available. Analysis of outcomes in specific settings, notably from low-middle income countries, is crucial. Objectives: To evaluate the patient profile and outcomes of neonates treated with iNO in our Level IIIB unit. Methods: This retrospective observational study describes the clinical diagnosis, management strategies and short-term outcomes of all neonates who received iNO in the years between 2013 and 2021. Details were retrieved from Electronic Medical Records and systematically analysed. Observation: Of 35 infants who received iNO during the study period, 31 (88.6%) were >34 weeks. The median and interquartile range (IQR) of oxygenation index at which iNO was started was 28 (20,33). The median (IQR) duration of iNO therapy was 48 (23,95) hours. Overall, 18 neonates (51.4%) survived till hospital discharge. Therapeutic response was best observed in infants with HRF secondary to meconium aspiration syndrome or congenital pneumonia (100% survival). Though the benefits of iNO use in congenital diaphragmatic hernia and bronchopulmonary dysplasia associated with PH are debatable, its use continues as a rescue measure. Conclusion: iNO is used in severe HRF associated with PH in neonates and can improve survival rates in select patient profiles without any major adverse outcomes.
背景:吸入型一氧化氮(iNO)治疗合并肺动脉高压(PH)的新生儿缺氧呼吸衰竭(HRF)已有几十年的历史。它的要求是不常见的,被认为是一种高级形式的支持,并不广泛使用。对特定环境,特别是中低收入国家的结果进行分析至关重要。目的:评估在我们的IIIB级病房接受iNO治疗的新生儿的患者概况和结果。方法:本回顾性观察研究描述了2013年至2021年间所有接受iNO治疗的新生儿的临床诊断、管理策略和短期结局。从电子病历中检索详细信息并进行系统分析。观察:在研究期间接受iNO治疗的35例婴儿中,31例(88.6%)>34周。iNO开始时氧合指数的中位数和四分位数范围(IQR)为28(20,33)。iNO治疗的中位(IQR)持续时间为48(23,95)小时。总体而言,18名新生儿(51.4%)存活至出院。治疗效果在胎粪吸入综合征或先天性肺炎继发HRF的婴儿中观察到最好(100%生存率)。尽管在与PH相关的先天性膈疝和支气管肺发育不良中使用iNO的益处尚存争议,但它仍被用作一种抢救措施。结论:iNO用于新生儿PH相关的严重HRF,可以提高特定患者的生存率,且无任何主要不良后果。
{"title":"Inhaled nitric oxide therapy for pulmonary arterial hypertension of newborn: Eight-year experience of a level IIIB unit","authors":"V. Anand, Femitha Pournami, A. Prithvi, Anand Nandakumar, Jyothi Prabhakar, Naveen Jain","doi":"10.4103/arwy.arwy_57_21","DOIUrl":"https://doi.org/10.4103/arwy.arwy_57_21","url":null,"abstract":"Background: Inhaled nitric oxide (iNO) has been in use for several decades now in neonates with hypoxic respiratory failure (HRF) associated with pulmonary hypertension (PH). Its requirement is uncommon, and is considered as an advanced form of support that is not widely available. Analysis of outcomes in specific settings, notably from low-middle income countries, is crucial. Objectives: To evaluate the patient profile and outcomes of neonates treated with iNO in our Level IIIB unit. Methods: This retrospective observational study describes the clinical diagnosis, management strategies and short-term outcomes of all neonates who received iNO in the years between 2013 and 2021. Details were retrieved from Electronic Medical Records and systematically analysed. Observation: Of 35 infants who received iNO during the study period, 31 (88.6%) were >34 weeks. The median and interquartile range (IQR) of oxygenation index at which iNO was started was 28 (20,33). The median (IQR) duration of iNO therapy was 48 (23,95) hours. Overall, 18 neonates (51.4%) survived till hospital discharge. Therapeutic response was best observed in infants with HRF secondary to meconium aspiration syndrome or congenital pneumonia (100% survival). Though the benefits of iNO use in congenital diaphragmatic hernia and bronchopulmonary dysplasia associated with PH are debatable, its use continues as a rescue measure. Conclusion: iNO is used in severe HRF associated with PH in neonates and can improve survival rates in select patient profiles without any major adverse outcomes.","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"25 1","pages":"19 - 24"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86724679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of airway societies in improving airway management 气道协会在改善气道管理中的作用
Pub Date : 2022-01-01 DOI: 10.4103/arwy.arwy_6_22
V. Ramkumar, B. Mcguire, S. Myatra, M. Sorbello, F. Urdaneta, J. Divatia
{"title":"Role of airway societies in improving airway management","authors":"V. Ramkumar, B. Mcguire, S. Myatra, M. Sorbello, F. Urdaneta, J. Divatia","doi":"10.4103/arwy.arwy_6_22","DOIUrl":"https://doi.org/10.4103/arwy.arwy_6_22","url":null,"abstract":"","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"1 1","pages":"1 - 3"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84362919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Airway Pharmacology and Treatment
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1